myelodysplasia

(redirected from Stem cell transplantation)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

my·e·lo·dys·pla·sia

 (mī′ə-lō-dĭs-plā′zhə)
n.
1. Abnormal development of the spinal cord.
2. Dysplasia of myelocytes and other cells in the bone marrow.

my′e·lo·dys·plas′tic (-plăs′tĭk) adj.
Translations

my·e·lo·dys·pla·si·a

n. mielodisplasia, desarrollo anormal de la columna vertebral.

myelodysplasia

n mielodisplasia
References in periodicals archive ?
Of these, only six survived a regime of stem cell transplantation - with five completely cured and disease free by the study's conclusion.
Additionally, the report provides an overview of key players involved in therapeutic development for Hematopoietic Stem Cell Transplantation and features dormant and discontinued projects.
The visiting doctor will also meet child patients who had undergone marrow and stem cell transplantation over the past years.
They noted that autologous hematopoietic stem cell transplantation can be considered for select patients at experienced institutions with severe myasthenia gravis for whom the risks of this procedure are outweighed by its potential benefits.
It also reviews key players involved in the therapeutic development for Hematopoietic Stem Cell Transplantation and special features on late-stage and discontinued projects.
NAC- SCRT has observed that several clinicians, companies , hospitals advertise stem cell based therapies other than haematopoietic stem cell transplantation for haematological disorders on their websites.
A snapshot of the global therapeutic scenario for Hematopoietic Stem Cell Transplantation.
Their study aimed at evaluating the efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with T2DM and who also had good glycemic control.
The donor is ready to provide bone marrow that can save my daughter's life," he said, adding that he has taken his daughter to Christian Medical College, Vellore, in India for initial treatment and to get ready for the stem cell transplantation.
The approved indication is for "unrelated donor hematopoietic stem cell transplantation procedures .
In the long anchor study, Terje Forslund, who is not further identified, looks at the impact on the kidney of stem cell transplantation to treat leukemia.
Because of their novelty, stem cell transplantation trials will necessarily involve high levels of indeterminacy regarding risks, methods, and standards.